The discovery of a new preclinical compound with strong antifungal activity against multidrug-resistant pathogens is ...

Multidrug-resistant (MDR) A. baumannii is a rapidly emerging pathogen in healthcare settings, where it causes infections that include bacteremia, pneumonia, meningitis, and urinary tract and wound ...

Dimicare Biotech and affiliated organizations have presented the discovery and preclinical characterization of DCB-001, a trichloroacetimidamide compound being developed as a novel precision ...

DR. MUBASHIR HUSSAIN ...

Copyright: © 2024 The Author(s). Published by Elsevier Ltd.

Responses to Senator Chuck Schumer’s reversal on the stopgap spending bill. Also: A Trump threat to law firms; the risk of TB ...

Multidrug resistance in cancer can be overcome by combining a drug that blocks a key enzyme with another anticancer drug, according to a study in preclinical models led by researchers at UT ...

Mycobacterium abscessus is a fast-growing, pathogenic mycobacteria that can cause lung infections, and people who have ...

In this pilot study, we used this technique to transfer the human multidrug resistance 1 gene into stem and progenitor cells of patients with germ cell tumors undergoing autologous transplantation.

Even though effective tuberculosis treatments exist, they're so hard to access in the developing world that more than one ...

Rapid and accurate diagnosis of bacterial infections is increasingly important in medical settings to combat the rise in multidrug-resistant (MDR) bacteria.